hydroxyurea has been researched along with Multiple Myeloma in 12 studies
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Loscocco, GG | 1 |
| Antonioli, E | 1 |
| Romano, I | 1 |
| Vergoni, F | 1 |
| Rotunno, G | 1 |
| Mannelli, F | 1 |
| Guglielmelli, P | 1 |
| Vannucchi, AM | 1 |
| Nishihori, T | 1 |
| Hassoun, Y | 1 |
| Zhang, L | 1 |
| Shain, K | 1 |
| Alsina, M | 1 |
| Kharfan-Dabaja, MA | 1 |
| Meyer, AN | 1 |
| McAndrew, CW | 1 |
| Donoghue, DJ | 1 |
| Yong, KL | 1 |
| Fahey, A | 1 |
| Pizzey, A | 1 |
| Linch, DC | 1 |
| Rechner, I | 1 |
| Brito-Babapulle, F | 1 |
| Fielden, J | 1 |
| DAVIS, P | 1 |
| Lewensohn, R | 1 |
| Ringborg, U | 1 |
| Cehreli, C | 1 |
| Undar, B | 1 |
| Akkoc, N | 1 |
| Onvural, B | 1 |
| Altungoz, O | 1 |
| Salmon, SE | 1 |
| Durie, BG | 1 |
| Alberts, DS | 1 |
| Golde, DW | 1 |
| Carter, SK | 1 |
| Mathé, G | 1 |
| Schneider, M | 1 |
| Schwarzenberg, L | 1 |
| Cattan, A | 1 |
| Amiel, JL | 1 |
| Schlumberger, JR | 1 |
2 reviews available for hydroxyurea and Multiple Myeloma
| Article | Year |
|---|---|
Coexistence of chronic neutrophilic leukemia with light chain myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Doxorubicin; Etoposide; Female; | 1994 |
An overview of the status of the nitrosoureas in other tumors.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Br | 1973 |
10 other studies available for hydroxyurea and Multiple Myeloma
| Article | Year |
|---|---|
Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Bone Marrow; Calreticulin; Dexamethas | 2021 |
High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation.
Topics: Bone Marrow; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; He | 2014 |
Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cells.
Topics: Apoptosis; Cell Line, Tumor; Fibroblast Growth Factor 2; Golgi Apparatus; Humans; Hydroxyurea; Lipox | 2008 |
Influence of cell cycling and cell division on transendothelial migration of CD34+ cells.
Topics: Adult; Antigens, CD34; Biomarkers; Bone and Bones; Cell Adhesion; Cell Movement; Cells, Cultured; Ch | 2002 |
Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capillary Leak Syndrome; Combined Modality Th | 2003 |
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA.
Topics: Antineoplastic Agents; Drug Therapy; Hodgkin Disease; Hydroxyurea; Leukopenia; Lymphoma; Lymphoma, L | 1964 |
DNA-repair synthesis in blast cells from patients with acute myeloblastic leukaemia.
Topics: Alkylating Agents; Autoradiography; Bone Marrow; Cell Transformation, Neoplastic; DNA; DNA Repair; H | 1982 |
Cellular kinetics in multiple myeloma. A new approach to staging and treatment.
Topics: Azathioprine; Bone and Bones; Bone Neoplasms; Cell Count; Computers; Cytarabine; Diagnosis, Computer | 1975 |
DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy.
Topics: Alkylating Agents; Autoradiography; Bone Marrow; Bone Marrow Cells; Cell Division; Cells, Cultured; | 1974 |
[Personal experience on the chemotherapy of leukemias and hematosarcomas].
Topics: Antineoplastic Agents; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Hydroxyurea; Leukemia; L | 1968 |